Highest development stage: Phase 4

Development active

Gram-positive activity

Mechanism of Action/Target pathogen: Approved for: acute bacterial skin and skin structure infections; other potential indications: hospital-acquired bacterial pneumonia/ventilator-acquired bacterial pneumonia